Michael E. Thase

47.3k total citations · 8 hit papers
563 papers, 30.9k citations indexed

About

Michael E. Thase is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, Michael E. Thase has authored 563 papers receiving a total of 30.9k indexed citations (citations by other indexed papers that have themselves been cited), including 319 papers in Pharmacology, 266 papers in Experimental and Cognitive Psychology and 139 papers in Psychiatry and Mental health. Recurrent topics in Michael E. Thase's work include Treatment of Major Depression (314 papers), Mental Health Research Topics (168 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (141 papers). Michael E. Thase is often cited by papers focused on Treatment of Major Depression (314 papers), Mental Health Research Topics (168 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (141 papers). Michael E. Thase collaborates with scholars based in United States, Canada and Germany. Michael E. Thase's co-authors include Greg J. Siegle, A. John Rush, John C. Markowitz, Susan G. Kornstein, Daniel N. Klein, Cameron S. Carter, Madhukar H. Trivedi, Stuart R. Steinhauer, James H. Kocsis and Rachel Manber and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Michael E. Thase

548 papers receiving 29.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

2003 3.0k citations Bruce A. Arnow, Daniel N. Klein et al. profile →
Frontiers of cognitive therapy

1997 808 citations Michael E. Thase profile →
Increased Amygdala and Decreased Dorsolateral Prefrontal BOLD Responses in Unipolar Depression: Related and Independent Features

2006 701 citations Michael E. Thase et al. profile →
Can’t shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals

2002 679 citations Michael E. Thase et al. profile →
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

2001 618 citations Michael E. Thase et al. profile →
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma

2003 569 citations Michael E. Thase, Daniel N. Klein et al. profile →
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression

2017 489 citations Richard C. Shelton, Michael E. Thase et al. profile →
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study

2019 483 citations Michael E. Thase et al. profile →

Peers

Countries citing papers authored by Michael E. Thase

Since Specialization

Citations

This map shows the geographic impact of Michael E. Thase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Thase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Thase more than expected).

Fields of papers citing papers by Michael E. Thase

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Thase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Thase. The network helps show where Michael E. Thase may publish in the future.

Co-authorship network of co-authors of Michael E. Thase

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Thase. A scholar is included among the top collaborators of Michael E. Thase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Thase. Michael E. Thase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recent developments pertaining to treatment‐resistant depression: a 40‐year perspective 2023 ·World Psychiatry ·Michael E. Thase	2
2	Do financial incentives increase mental health treatment engagement? A meta-analysis. 2022 ·Journal of Consulting and Clinical Psychology ·Gabriela Kattan Khazanov, Paige E. Morris, (unknown), Shari Jager‐Hyman, (unknown), James R. McKay, Richard Feinn, Elaine M. Boland, Michael E. Thase	9
3	Addressing anhedonia to increase depression treatment engagement 2021 ·British Journal of Clinical Psychology ·Gabriela Kattan Khazanov, Courtney N. Forbes, Barnaby D. Dunn, Michael E. Thase	25
4	The natural history of insomnia: Does sleep extension differentiate between those that do and do not develop chronic insomnia? 2021 ·Journal of Sleep Research ·Michael L. Perlis, Knashawn H. Morales, Iván Vargas, Donn Posner, Michael A. Grandner, (unknown), (unknown), Nalaka S. Gooneratne, Jacqueline D. Kloss, (unknown), (unknown), Michael E. Thase, Jason Ellis	8
5	Vortioxetine: a New Treatment for Major Depressive Disorder 2015 ·Expert Opinion on Pharmacotherapy ·(unknown), Michael E. Thase	63
6	Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder 2015 ·The Journal of Clinical Psychiatry ·Michael E. Thase, James M. Youakim, Aleksandar Skuban, Mary Hobart, (unknown), Peter Zhang, Robert D. McQuade, William H. Carson, Margaretta Nyilas, Raymond Sanchez, Hans Eriksson	145
7	Depression: Addressing Partial Response After First-Line Antidepressant Treatment 2014 ·The Journal of Clinical Psychiatry ·Michael E. Thase, Maurizio Fava, Andrew A. Nierenberg	0
8	An Overview of Vortioxetine 2014 ·The Journal of Clinical Psychiatry ·Alan F. Schatzberg, Pierre Blier, Larry Culpepper, Rakesh K. Jain, George I. Papakostas, Michael E. Thase	22
9	The cardiovascular safety profile of escitalopram 2013 ·European Neuropsychopharmacology ·Michael E. Thase, Klaus Groes Larsen, Elin Heldbo Reines, Sidney H. Kennedy	37
10	Antidepressant Combinations: Cutting Edge Psychopharmacology or Passing Fad? 2013 ·Current Psychiatry Reports ·Michael E. Thase	9
11	Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination 2009 ·Journal of Affective Disorders ·Rachel Maddux, Lawrence P. Riso, Daniel N. Klein, John C. Markowitz, Barbara O. Rothbaum, Bruce A. Arnow, Rachel Manber, Janice A. Blalock, Gabor I. Keitner, Michael E. Thase	27
12	Remission is the optimal goal of acute phase antidpressant therapy 2008 ·Actas Españolas de Psiquiatría ·Michael E. Thase	2
13	Efficacy of Duloxetine and Selective Serotonin Reuptake Inhibitors 2007 ·Journal of Clinical Psychopharmacology ·Michael E. Thase, Yili Pritchett, (unknown), Ralph Swindle, Jimmy Yu Xu, Michael J. Detke	90
14	The role of therapist adherence, therapist competence, and alliance in predicting outcome of individual drug counseling: Results from the National Institute Drug Abuse Collaborative Cocaine Treatment Study 2006 ·Psychotherapy Research ·Jacques P. Barber, Robert Gallop, Paul Crits‐Christoph, Arlene Frank, Michael E. Thase, Roger D. Weiss, Mary Beth Connolly Gibbons	137
15	A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness 2005 ·The Journal of Clinical Psychiatry ·Maurizio Fava, Michael E. Thase, Charles DeBattista	141
16	Effectiveness of St John's wort in major depression: a randomized controlled trial. 2001 ·PubMed ·Richard C. Shelton, Martín Keller, Alan J. Gelenberg, David L. Dünner, Robert M. A. Hirschfeld, Michael E. Thase, James Russell, R. Bruce Lydiard, (unknown), (unknown), (unknown), David J. Hellerstein, Paul J. Goodnick, Gabor I. Keitner, Stephen M. Stahl, Uriel Halbreich	241
17	Efficacy of Mirtazapine for Prevention of Depressive Relapse 2001 ·The Journal of Clinical Psychiatry ·Michael E. Thase, Andrew A. Nierenberg, Martín Keller, (unknown)	65
18	Male depression, alcoholism and violence 2000 ·Ihsan M. Salloum, Dennis C. Daley, Michael E. Thase	7
19	Summary: Defining Remission in Patients Treated With Antidepressants 1999 ·Michael E. Thase	3
20	Response to cognitive-behavioral therapy in chronic depression. 1994 ·Michael E. Thase, Charles F. Reynolds, Ellen Frank, Anne D. Simons	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact